Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by The300on Aug 28, 2011 1:06pm

254 Views

Post# 18987352

Cambridge Conference in TO

Just checked exhibitor list and it looks like Halo is not attending
.
https://cambridgehouse.com/conference-details/toronto-resource-investment-conference-2011/32

I interpret this to mean that Halo will continue with their prolonged "quite period".

As always, IMHO

Regards,
The 300

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario